X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (60) 60
index medicus (42) 42
oncology (26) 26
male (24) 24
hematology (23) 23
cell line, tumor (21) 21
animals (20) 20
antineoplastic agents - pharmacology (17) 17
cancer (16) 16
proteins (15) 15
expression (14) 14
human necessities (14) 14
hygiene (14) 14
imatinib mesylate (14) 14
medical or veterinary science (14) 14
mice (14) 14
preparations for medical, dental, or toilet purposes (14) 14
adult (13) 13
apoptosis - drug effects (13) 13
investigating or analysing materials by determining theirchemical or physical properties (13) 13
measuring (13) 13
physics (13) 13
piperazines - pharmacology (13) 13
pyrimidines - pharmacology (13) 13
testing (13) 13
aged (12) 12
analysis (12) 12
cell proliferation (12) 12
cell proliferation - drug effects (12) 12
chronic myeloid-leukemia (12) 12
medicine (12) 12
middle aged (12) 12
apoptosis (11) 11
proteomics (11) 11
610 medicine & health (10) 10
benzamides (10) 10
cell biology (10) 10
chronic myelogenous leukemia (10) 10
clinic for hematology (10) 10
research article (10) 10
stem cells (10) 10
telomere (10) 10
biochemical research methods (9) 9
biochemistry & molecular biology (9) 9
chronic myeloid leukemia (9) 9
multidisciplinary sciences (9) 9
prostate cancer (9) 9
science (9) 9
specific therapeutic activity of chemical compounds ormedicinal preparations (9) 9
biology (8) 8
female (8) 8
kinases (8) 8
leukemia (8) 8
leukemia, myelogenous, chronic, bcr-abl positive - pathology (8) 8
lysine - analogs & derivatives (8) 8
telomerase (8) 8
tumors (8) 8
bone marrow (7) 7
cells (7) 7
electrophoresis, gel, two-dimensional (7) 7
inhibition (7) 7
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (7) 7
oxidoreductases acting on ch-nh group donors - metabolism (7) 7
prostatic neoplasms - pathology (7) 7
proteomics - methods (7) 7
reverse transcriptase polymerase chain reaction (7) 7
tyrosine (7) 7
down-regulation (6) 6
drug resistance, neoplasm (6) 6
drug resistance, neoplasm - drug effects (6) 6
eif5a (6) 6
flow-cytometry (6) 6
gene expression (6) 6
identification (6) 6
imatinib (6) 6
in-vitro (6) 6
lysine - metabolism (6) 6
mixed function oxygenases - metabolism (6) 6
peptide initiation factors - metabolism (6) 6
piperazines - therapeutic use (6) 6
proliferation (6) 6
prostatic neoplasms - metabolism (6) 6
protein-tyrosine kinases - antagonists & inhibitors (6) 6
proteome (6) 6
pyrimidines - therapeutic use (6) 6
research (6) 6
rna-binding proteins - metabolism (6) 6
adolescent (5) 5
aged, 80 and over (5) 5
aurora kinases (5) 5
bcr-abl (5) 5
biomarkers (5) 5
blotting, western (5) 5
cancer-cells (5) 5
care and treatment (5) 5
cell cycle - drug effects (5) 5
cisplatin (5) 5
disease models, animal (5) 5
gene expression regulation, neoplastic (5) 5
gene expression regulation, neoplastic - drug effects (5) 5
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (133) 133
Bulgarian (9) 9
German (9) 9
French (6) 6
Finnish (4) 4
Norwegian (1) 1
Portuguese (1) 1
Spanish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


DISEASE MARKERS, ISSN 0278-0240, 09/2019, Volume 2019, pp. 1 - 14
Journal Article
2000, 1. izd., Bŭlgarsko arkhitekturno nasledstvo, ISBN 9789548931052, 372
Book
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2585 - 2585
Abstract Introduction: Classical Dyskeratosis Congenita (DKC) is a systemic disorder characterized mainly by mucocutaneous features and bone marrow failure.... 
Journal Article
American Journal of Physiology - Renal Physiology, ISSN 1931-857X, 10/2012, Volume 303, Issue 7, pp. 1015 - 1025
Journal Article
Molecular Cancer, ISSN 1476-4598, 10/2011, Volume 10, Issue 1, pp. 129 - 129
Journal Article
International Journal of Cancer, ISSN 0020-7136, 05/2016, Volume 138, Issue 10, pp. 2450 - 2465
Despite recent advances in the treatment of metastatic castration‐resistant prostate cancer (CRPC), outcome of patients remains poor due to the development of... 
castration‐resistant prostate cancer | anti‐metastatic activity | apoptosis | frondoside A | autophagy | anti-metastatic activity | castration-resistant prostate cancer | CELLS | DOCETAXEL | SEA | INHIBITION | ANTICANCER | ONCOLOGY | ENZALUTAMIDE RESISTANCE | EXPRESSION | AAPTAMINE | Triterpenes - pharmacology | Apoptosis - drug effects | Humans | Drug Resistance, Neoplasm | Male | Autophagy - drug effects | Prostatic Neoplasms, Castration-Resistant - genetics | Prostatic Neoplasms, Castration-Resistant - pathology | Apoptosis Regulatory Proteins - genetics | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Disease Models, Animal | Cell Survival - drug effects | Tumor Stem Cell Assay | Reproducibility of Results | Prostatic Neoplasms, Castration-Resistant - drug therapy | Glycosides - pharmacology | Prostatic Neoplasms, Castration-Resistant - metabolism | Apoptosis Regulatory Proteins - metabolism | Xenograft Model Antitumor Assays | Animals | Cell Cycle Checkpoints - drug effects | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Proteins | Keratin | Drug resistance | Prostate cancer | Analysis | Rodents | Medical prognosis | Cell cycle | Metastasis | Autophagy | Apoptosis | Cell proliferation | Drugs | Alternative splicing | Bax protein | Bcl-2 protein | Toxicity | Drug development | Caspase-3 | Immunosuppressive agents | Metastases | Castration | Down-regulation | Interleukin 1 | Cathepsin B | Cleavage | Inhibition | Cell survival | Immunomodulation | Tumor cells | Caspase | Poly(ADP-ribose) polymerase | Androgens | Lungs | Cell lines | Bcl protein | Phagocytosis | Index Medicus
Journal Article
Drug Discovery Today: Technologies, ISSN 1740-6749, 03/2014, Volume 11, Issue 1, pp. 89 - 99
Resistance against tyrosine kinase inhibitors (TKIs) represents a relevant clinical problem in treatment of chronic myelogenous leukemia (CML). On the basis of... 
Drug Resistance, Neoplasm | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Tyrosine | Phenols | Chronic myeloid leukemia
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 12, p. e15992
Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. Survival of CLL cells depends on their close contact with stromal cells in... 
RHEUMATOID-ARTHRITIS | ANTIBODIES | LYMPHOMAS | APOPTOSIS | CLL | VIMENTIN | SPECIFICITY | IMMUNOGLOBULIN GENES | CALRETICULIN | BIOLOGY | EXPRESSION | Recombinant Proteins - metabolism | Complementarity Determining Regions - genetics | Humans | Immunoglobulin G - chemistry | Electrophoresis, Gel, Two-Dimensional - methods | Recombinant Proteins - chemistry | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization - methods | Stromal Cells - immunology | Receptors, Antigen, B-Cell - metabolism | Antigens - chemistry | Calreticulin - chemistry | Microscopy, Fluorescence - methods | Leukemia, Lymphocytic, Chronic, B-Cell - metabolism | Leukocytes, Mononuclear - cytology | HeLa Cells | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | Vimentin - chemistry | Autoimmunity | Chronic lymphocytic leukemia | Immunity | Intermediate filament proteins | Vimentin | Cell culture | Leukemia | Otolaryngology | Oncology | Stimulation | B-cell receptor | Kinases | Proteins | Receptors | Calreticulin | Complementarity-determining region | Bone marrow | Complementarity-determining region 3 | Recombinant | Antigens | Immunoglobulins | Chronic lymphatic leukemia | Autoantibodies | Cell survival | Complementarity | Cytokines | Hematology | Secretion | Lymphatic leukemia | Survival | Molecular chains | Hypotheses | Lymphocytes B | Rheumatoid arthritis | Stromal cells | Autoimmune diseases | Cancer | Apoptosis
Journal Article
Annals of Hematology, ISSN 0939-5555, 2/2018, Volume 97, Issue 2, pp. 277 - 287
Standard of care for untreated mantle cell lymphoma (MCL) is still debated. At the University Hospital Zurich, advanced MCL in physically fit patients is... 
Health-related quality of life | Economic burden | Medicine & Public Health | Hematology | Mantle cell lymphoma | Oncology | R-CHOP/HD-ASCT | R-hyper-CVAD/MTX-AraC | EUROPEAN-MCL-NETWORK | MTX/ARA-C | IMMUNOCHEMOTHERAPY | PROGRESSION-FREE SURVIVAL | FOLLOW-UP | PHASE-II | TRANSPLANTATION | MULTICENTER TRIAL | RITUXIMAB | QUALITY-OF-LIFE | HEMATOLOGY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Lymphoma, Mantle-Cell - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Hospitalization - statistics & numerical data | Dexamethasone - adverse effects | Male | Transplantation, Autologous | Cytarabine - adverse effects | Cyclophosphamide - adverse effects | Prednisone - economics | Lymphoma, Mantle-Cell - mortality | Antineoplastic Combined Chemotherapy Protocols - economics | Vincristine - administration & dosage | Adult | Female | Quality of Life - psychology | Retrospective Studies | Doxorubicin - administration & dosage | Cytarabine - economics | Cyclophosphamide - economics | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Prednisone - adverse effects | Drug Administration Schedule | Vincristine - economics | Antibodies, Monoclonal, Murine-Derived - economics | Doxorubicin - economics | Hematopoietic Stem Cell Transplantation | Remission Induction | Cytarabine - administration & dosage | Lymphoma, Mantle-Cell - therapy | Lymphoma, Mantle-Cell - psychology | Survival Analysis | Vincristine - adverse effects | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Dexamethasone - economics | Doxorubicin - adverse effects | Hospitalization - economics | Care and treatment | Anthracyclines | Chemotherapy | Corticosteroids | Stem cells | Lymphomas | Dosage and administration | Transplantation | Methotrexate | Hematopoietic stem cells | Cancer | Index Medicus
Journal Article
Journal Article
PROTEOMICS, ISSN 1615-9853, 06/2017, Volume 17, Issue 11, pp. 1700048 - n/a
Rhizochalinin (Rhiz) is a novel marine natural sphingolipid‐like compound, which shows promising in vitro and in vivo activity in human castration‐resistant... 
Rhizochalinin | ERK1/2 | Ingenuity pathway analysis (IPA) | Prostate cancer | Antimigratory activity | GERM-CELL CANCER | MIGRATION | ALKALOID MONANCHOCIDIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | INDUCTION | INDUCED NEOPLASTIC TRANSFORMATION | IN-VITRO | INHIBITION | CYTOTOXIC PROPERTIES | PROSTATE-CANCER | CASTRATION-RESISTANT | Prostatic Neoplasms - metabolism | Keratins, Type II - metabolism | Humans | Male | LIM Domain Proteins - metabolism | Fatty Alcohols - pharmacology | Rhizoctonia - chemistry | Interleukin-1beta - metabolism | Cytoskeletal Proteins - metabolism | Antineoplastic Agents - pharmacology | Membrane Proteins - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Proteomics - methods | Prostatic Neoplasms - drug therapy | Fibroblasts - metabolism | Prostatic Neoplasms - pathology | Cells, Cultured | Proteome - analysis | HSP70 Heat-Shock Proteins - metabolism | Cell Movement - drug effects | MAP Kinase Signaling System - drug effects | Fibroblasts - drug effects | Cell Proliferation - drug effects | Adaptor Proteins, Signal Transducing - metabolism | Keratins, Hair-Specific - metabolism | Stathmin - metabolism | Drug Screening Assays, Antitumor | Proteins | Keratin | Care and treatment | Analysis | Investigations | Cancer | Surgical implants | Leukocyte migration | Biochemistry | Western blotting | Cell adhesion & migration | Anticancer properties | Synergistic effects | Biomedical materials | Functional anatomy | Antitumor agents | Castration | Interleukin 1 | Biocompatibility | Activation analysis | Extracellular signal-regulated kinase | Data processing | Biological activity | Mode of action | Stathmin | Screening | Molecular modelling | Inhibitors | Proteomics | Isoforms | In vivo methods and tests | ATP | Prostate | In vitro methods and tests | Cell migration | Adenosine triphosphatase
Journal Article